July 22, 2026 at 10:16 AM 2 min readhealthNews Insights

Draft National Health Research Policy 2026 Proposes Six-Fold Increase In Government Spending

The policy aims to shift scientist evaluation from publication counts to clinical translation impact.

[Policy Overhaul Objectives]:

The Centre's Draft National Health Research Policy 2026, currently open for public consultation until July 27, aims to fundamentally restructure India's health research ecosystem. The policy seeks to align research efforts more closely with the nation's specific disease burden and public health priorities. A central pillar of this proposal is a significant increase in government funding, targeting a rise from the current approximately 0.024% of GDP to 0.15% by 2047.

[Governance and Evaluation Framework]:

To ensure strategic coordination, the draft outlines a new three-tier governance structure. This includes the National Health Research Stewardship Committee, the Department of Health Research, and the Indian Council of Medical Research (ICMR). Furthermore, the policy introduces a shift in how scientists are evaluated. Moving away from traditional publication counts, the new framework will prioritize clinical translation and policy influence, aiming to foster research that has a tangible impact on patient outcomes and public health strategies.

[Decentralization and Implementation]:

The policy also emphasizes the decentralization of institutional research capacity across the country. By streamlining ethical approvals for multi-center clinical trials, the government hopes to accelerate the pace of medical innovation. This comprehensive approach is designed to create a more robust and responsive research environment, ensuring that India's scientific community is better equipped to address both current and future health challenges effectively. The consultation period remains a critical window for stakeholders to provide input.
Pulse Intelligence
Context & Impact
  • The current health research spending in India is approximately 0.024% of GDP.
  • The ICMR is a key body involved in the proposed three-tier governance structure.
  • Public consultation for the draft policy is scheduled to conclude on July 27.
  • Increased funding could significantly boost the capacity for domestic clinical trials and medical innovation.
  • The new evaluation framework may change how academic and research institutions prioritize their projects.
  • Streamlined ethical approvals could reduce the time required to bring new medical solutions to the public.

Not applicable.

The Indus Pulse is committed to accuracy and transparency.
Report a CorrectionEditorial Standards